NSEMemorandum of Understanding/Agreements4 Aug 2026 · 4 Aug 2026, 07:28 pm
Memorandum of Understanding/Agreements
Healthcare Global Enterprises Limited · HCG
✦ AI SummaryM&A
Healthcare Global Enterprises Limited has entered into an agreement to acquire a 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited through the subscription of equity shares for an aggregate consideration of INR 38 lakh.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations ), we would like to inform that HCG Manavata Oncology LLP ( LLP ), a subsidiary LLP of Healthcare Global Enterprises Limited ( Company ) has entered into an agreement to acquire 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited ( EVRE ) through subscription of equity shares for an aggregate consideration of INR 38 lakh to qualify as a captive user of the power plant operated by EVRE.
Attachments (1)
📄pdf
Download →
HCG1_04082026192752_Disclosure_HCG_Manvata_Acquisition.pdf
View document text
August 04, 2026
National Stock Exchange of India Limited, BSE Limited,
Compliance Department, Compliance Department,
Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers,
Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001,
Maharashtra, India Maharashtra, India
Dear Sir/Madam,
Subject : Intimation under Regulation 30 read with Schedule III of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015
Stock Code : BSE – 539787, NSE – HCG
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (‘SEBI Listing Regulations’), we would like to inform that HCG Manavata
Oncology LLP (“LLP”), a subsidiary LLP of Healthcare Global Enterprises Limited
(“Company”) has entered into an agreement to acquire 26% equity stake in Epic Vighnaharta
Renewable Energy Private Limited (“EVRE”) through subscription of equity shares for an
aggregate consideration of INR 38 lakh.
Following the completion of the acquisition, the LLP will hold a 26% stake in EVRE, on a
fully diluted basis, and consequently, the Company will have an indirect interest of up to 26%
in EVRE.
We are enclosing herewith the brief details of the above as prescribed under SEBI Listing
Regulations, read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated January 30, 2026, in respect of the aforesaid entity as Annexure A.
We would request you to please take note of the above and bring the same to the notice of all
concerned.
The above information is also available on the website of the Company at:
https://www.hcgoncology.com
Thanking you,
For HealthCare Global Enterprises Limited
Sunu Manuel
Company Secretary & Compliance Officer
Encl: a/a
HealthCare Global Enterprises Limited
Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India
Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India
91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489
Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag
Annexure A
Relevant details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 read along with the SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Sr. Particulars Details of Epic Vighnaharta Renewable Energy
No. Private Limited
1. Name of the Target Company, Name: Epic Vighnaharta Renewable Energy Private
details in brief such as size, Limited (“EVRE”)
turnover, etc.
Brief Details: EVRE is primarily engaged in the
business of power generation from renewable power
plants.
Authorized Share Capital (FY26): ₹ 1,00,000
Revenue from Operations (FY26): ₹ NIL
2. Whether the acquisition would fall No, the transaction does not fall within the ambit of
within the related party a related party transaction. The LLP, which is a
transaction(s) and whether the subsidiary of the Company, proposes to acquire a
promoter /promoter group/ group stake of 26% in EVRE. Except to the extent of
companies have any interest in the indirect interest in EVRE through the LLP, neither
entity being acquired? the promoter/promoter group nor any group
company has any direct interest in EVRE.
If yes, nature of interest and details
thereof and whether the same is
done at "arm’s length"
3. Industry to which the entity being Power Generation and Clean Energy Development
acquired belongs
4. Objects and impact of acquisition EVRE is a power project developer, which is setting
(including but not limited to, up a solar power plant in Mangalwedha, District
disclosure of reasons for Solapur, in the State of Maharashtra. The LLP would
acquisition of target entity, if its acquire 26% stake in EVRE to qualify as a captive
business is outside the main line of user of the power plant operated by EVRE, so that
business of the listed entity) EVRE can supply the electricity generated by its
plant to the LLP for its own use.
HealthCare Global Enterprises Limited
Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India
Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India
91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489
Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag
5. Brief details of any governmental No specific governmental or regulatory approvals
or regulatory approvals required are required for incorporation, except such
for the acquisition approvals, registrations or licenses as may be
required in the ordinary course of business.
6. Indicative time period for The acquisition is expected to be completed in Q2
completion of the acquisition FY 2027 upon fulfilment of the terms and conditions
stipulated under the agreement executed for the
acquisition of stake in EVRE by the LLP.
7. Consideration - whether Cash Cash Consideration
consideration or share swap or any
other form and details of the same
8. Cost of acquisition and/or the Cost of acquisition- INR 38 lakh
price at which shares are acquired
9. Percentage of shareholding/ 3,80,000 Equity Shares of INR 10 each constituting
control acquired and/ or number of 26% of share capital of EVRE.
shares acquired
10. Brief background about the entity EVRE was incorporated on March 22, 2025, as per
acquired in terms of product/line the provisions of the Companies Act, 2013, bearing
of and business acquired, date of corporate identification number
incorporation, history of last 3 U35105MH2025PTC443553 and having its
years turnover, country in which registered office at A-105B, Gokul Arcade, Swami
the acquired entity has presence Nityanand Marg, Vile Parle East, Mumbai 400053.
and any other significant
information (in brief) EVRE is a power project developer and is setting up
a solar power plant in Mangalwedha, District
Solapur, in the State of Maharashtra, with an initial
capacity of 1.3 MWp.
Date of incorporation – March 22, 2025
EVRE has presence in India.
EVRE’s Revenue from Operations in last 3 years –
FY25-26: INR NIL
FY24-25: INR NIL
FY23-24: INR NIL
HealthCare Global Enterprises Limited
Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India
Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India
91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489
Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag